TOP STORIES

• REGULATORY MHLW Approves Sakigake-Designated HAE Treatment, Lilly’s Migraine Med, Takeda’s Alunbrig, Ono’s Cachexia Drug, and More
  January 25, 2021

• BUSINESS Genmab Poised to Triple Japan Staff for Stand-Alone Biz, First Up Is ADC for Cervical Cancer
  January 22, 2021

• BUSINESS Moderna’s COVID-19 Shot Enters Clinical Trial in Japan: Takeda
  January 21, 2021

• REGULATORY Kobayashi Kako Submits Report on Drug Mix-Up, Could Face Administrative Penalty in 1st Half of February
  January 21, 2021

• REGULATORY Japan, Pfizer Finalize COVID-19 Vaccine Deal, Agree on Supply of 144 Million Doses
  January 21, 2021

• BUSINESS Will Cymbalta, E Keppra Face Generic Competition This Year? Vesicare, Aloxi Too?
  January 20, 2021

• REGULATORY MHLW Eyes 1st Revision of Drug Industry Vision in 8 Years as Off-Year Re-Pricing Takes Shape: Official
  January 19, 2021

• REGULATORY Kono Responsible for Logistics Part of COVID-19 Vaccine Rollout
  January 19, 2021

• REGULATORY Kono Tapped to Oversee COVID-19 Vaccine Rollout
  January 19, 2021

• BUSINESS BIKEN to Stop Shipment of Japanese Encephalitis Vaccine on Bacterial Contamination
  January 18, 2021

• REGULATORY Special Mitigation Margin for COVID-19 Up for Debate towards FY2022 Drug Price Revision: MHLW Bureau Chief
  January 15, 2021

• BUSINESS Nichi-Iko Announces Yet Another Recall, 38 Products Added to Bring Total to 75
  January 14, 2021

• ORGANIZATION Generic Use Targets Should Be Set by City/Ward in Major Prefectures: Professor
  January 14, 2021

• REGULATORY MHLW to Run Fresh Survey on Drug Makers’ Responses to Promotion Guidelines
  January 13, 2021

• BUSINESS Kobayashi Kako Expected to Face Administrative Penalty This Fiscal Year, Biz Suspension Likely
  January 12, 2021

• BUSINESS Drug Makers, Wholesalers Boost WFH as Japan Declares Second Emergency
  January 12, 2021

• COMMENTARY Potential Reimbursement Challenges of Aducanumab Could Usher in Health Insurance Overhaul in Japan
  January 8, 2021

• REGULATORY PMDA Updates Veklury Label to Allow Its Use in Moderate COVID-19
  January 8, 2021

• ORGANIZATION Japan Pharma Lobbies Shifting to Manabe/Okada Leadership? Their Abilities Will Be Tested as Industry Grapples with Thorny Issues
  January 7, 2021

• ACADEMIA Japan Reports Mother-to-Infant Cervical Tumor Transmission via Amniotic Fluids
  January 7, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 107
• 108
• 109
• 110
• 111
• 112
• 113
• 114
• 115
• …
• Next ›
• 最終 »